| Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure JR Castillo-Mancilla, JH Zheng, JE Rower, A Meditz, EM Gardner, ... AIDS research and human retroviruses 29 (2), 384-390, 2013 | 341 | 2013 |
| Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection PL Anderson, JJ Kiser, EM Gardner, JE Rower, A Meditz, RM Grant Journal of antimicrobial chemotherapy 66 (2), 240-250, 2011 | 240 | 2011 |
| Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detection LR Bushman, JJ Kiser, JE Rower, B Klein, JH Zheng, ML Ray, ... Journal of pharmaceutical and biomedical analysis 56 (2), 390-401, 2011 | 121 | 2011 |
| Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy TH Kiser, DN Fish, CL Aquilante, JE Rower, MF Wempe, R MacLaren, ... Critical Care 19, 1-9, 2015 | 91 | 2015 |
| Intracellular tenofovir and emtricitabine anabolites in genital, rectal, and blood compartments from first dose to steady state SM Seifert, X Chen, AL Meditz, JR Castillo-Mancilla, EM Gardner, ... AIDS research and human retroviruses 32 (10-11), 981-991, 2016 | 83 | 2016 |
| Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers JJ Kiser, JB Bumpass, AL Meditz, PL Anderson, L Bushman, M Ray, ... Antimicrobial agents and chemotherapy 54 (12), 4999-5003, 2010 | 67 | 2010 |
| State-of-the-art review on physiologically based pharmacokinetic modeling in pediatric drug development V Yellepeddi, J Rower, X Liu, S Kumar, J Rashid, CMT Sherwin Clinical pharmacokinetics 58, 1-13, 2019 | 62 | 2019 |
| Impact of the CYP2C8 *3 polymorphism on the drug–drug interaction between gemfibrozil and pioglitazone CL Aquilante, LA Kosmiski, DWA Bourne, LR Bushman, EB Daily, ... British journal of clinical pharmacology 75 (1), 217-226, 2013 | 61 | 2013 |
| A population pharmacokinetic-pharmacogenetic analysis of atazanavir DA Kile, S MaWhinney, CL Aquilante, JE Rower, JR Castillo-Mancilla, ... AIDS research and human retroviruses 28 (10), 1227-1234, 2012 | 60 | 2012 |
| Zidovudine and lamivudine for HIV infection PL Anderson, JE Rower Clinical medicine reviews in therapeutics 2010 (2), 115-127, 2010 | 57 | 2010 |
| Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma JE Rower, X Liu, T Yu, M Mundorff, CMT Sherwin, MD Johnson European journal of clinical pharmacology 73, 325-331, 2017 | 43 | 2017 |
| Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections KM Job, J Olson, C Stockmann, JE Constance, EY Enioutina, JE Rower, ... Expert review of anti-infective therapy 14 (8), 731-746, 2016 | 39 | 2016 |
| AUC‐guided vancomycin dosing in adolescent patients with suspected sepsis S Lanke, T Yu, JE Rower, AH Balch, EK Korgenski, CM Sherwin The Journal of Clinical Pharmacology 57 (1), 77-84, 2017 | 35 | 2017 |
| Optimizing the use of intravenous magnesium sulfate for acute asthma treatment in children X Liu, T Yu, JE Rower, SC Campbell, CMT Sherwin, MD Johnson Pediatric pulmonology 51 (12), 1414-1421, 2016 | 35 | 2016 |
| Inhaled remimazolam potentiates inhaled remifentanil in rodents T Bevans, C Deering-Rice, C Stockmann, J Rower, D Sakata, C Reilly Anesthesia & Analgesia 124 (5), 1484-1490, 2017 | 34 | 2017 |
| Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection LS Wu, JE Rower, JR Burton, PL Anderson, KP Hammond, ... Antimicrobial agents and chemotherapy 59 (4), 2179-2188, 2015 | 34 | 2015 |
| Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasma JE Rower, B Klein, LR Bushman, PL Anderson Biomedical Chromatography 26 (1), 12-20, 2012 | 33 | 2012 |
| Serum and cellular ribavirin pharmacokinetic and concentration–effect analysis in HCV patients receiving sofosbuvir plus ribavirin JE Rower, EG Meissner, LC Jimmerson, A Osinusi, Z Sims, T Petersen, ... Journal of Antimicrobial Chemotherapy 70 (8), 2322-2329, 2015 | 32 | 2015 |
| Validation and application of a liquid chromatography-tandem mass spectrometry method to determine the concentrations of sofosbuvir anabolites in cells JE Rower, LC Jimmerson, X Chen, JH Zheng, A Hodara, LR Bushman, ... Antimicrobial Agents and Chemotherapy 59 (12), 7671-7679, 2015 | 30 | 2015 |
| Measurement of intracellular ribavirin mono-, di-and triphosphate using solid phase extraction and LC–MS/MS quantification LC Jimmerson, ML Ray, LR Bushman, PL Anderson, B Klein, JE Rower, ... Journal of Chromatography B 978, 163-172, 2015 | 30 | 2015 |
